This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Identifying branded drugs with a low likelihood of generic entry has become a crucial strategy for companies looking to expand their product portfolio through in-licensing. This approach not only helps maintain market exclusivity but also ensures a steady revenue stream for pharmaceutical companies.
SAVE THE DATE – PMN Fall 2021 Summit: Pharma-Marketing Innovations & Trends of 2021 | SEP. Pharmaceutical brands must adapt to this new modality and pivot their promotional efforts to ensure that they can leverage the Telehealth channel effectively. Marketing Agility – the Path to Digital Engagement & Innovation.
COVID-19 has disrupted markets and accelerated digital adoption but what does this mean for the future of marketing? In this feature, Grünenthal’s Florent Eduoard and Kate Hurtig outline their principles for a new pharmaceutical marketing model. . The R&D focus began to shift, and so did the marketing.
BigData in healthcare refers to the vast amount of data that is continuously expanding and cannot be efficiently stored or processed using traditional tools. It accounts for the majority of bigdata in healthcare and comprises information, such as medical images, surveys, chats, and written narratives.
In 2025, pharmaceutical trends are redefining how brands connect with healthcare professionals (HCPs), patients, and stakeholders. Marketers must adapt to cutting-edge technology, personalized engagement, and regulatory shifts to stay ahead. But what exactly is shaping the future of pharma marketing this year?
Table of Contents Sr# Headings 1 Introduction: Why Staying Updated on Pharma News Matters 2 Emerging Trends in Pharma Marketing 3 The Role of Technology in Modern Pharma Strategies 4 Adapting to Regulatory Changes and Compliance Introduction: Why Staying Updated on Pharma News Matters In the fast-paced pharmaceutical industry, information is power.
Re:Imagine Pharma Marketing: How Pharma Marketing is Evolving in 2020. On November 9-11, 2020, Imagine Pharma Marketing held a virtual conference that discussed the roadmap for embedding long term commercial evolution in marketing. These changes include marketing processes, customer engagement, tools and tactics. .
As the landscape evolves, pharma executives must adapt their marketing strategies to remain competitive and effectively reach their target audiences. The rise of bigdata analytics, artificial intelligence, and machine learning has revolutionized drug discovery, development, and marketing.
Cloud-Based Clinical Database Systems : Leveraging cloud technology to streamline data management and collaboration. Advanced Data Analytics : Utilizing bigdata and machine learning to derive data-driven perspectives from clinical trial data.
Related: Nestlé Expands Use of Blockchain Technology to Its Coffee Brand. One way to prevent this is for designated agencies to judge the quality of smartphone measurements, as more food testing technologies come on the market. Other researchers are also testing bigdata algorithms to see how well they can predict food fraud.
Digital health investments skyrocketed in 2021, increasing 79% from 2020, according to a year-end report by CB Insights , a marketing intelligence firm. We also sensed that we’ll see more acquisitions of biotech companies by big tech as they make even bigger bets to break into the healthcare space.
As we approach 2025, the pharmaceutical industry is witnessing a seismic shift in marketing strategies, driven by technological advancements and evolving consumer expectations. This article explores the top pharma marketing trends that are set to redefine the landscape in the coming years.
Listen to how pharmaceutical brands and clinicians are adapting to this new modality and are pivoting their promotional efforts to ensure that they can leverage the Telehealth channel effectively. Panelists: Tim Glennon , Vice President of Marketing, Evofem Biosciences. Tres Garcia , Director Marketing, Agile Chapter Lead, Merck.
German and Swiss pharma companies dominated the Swedish market at this time and it wasn’t until 1913 that the discussions were turned into a pharmaceutical company, Astra AB. Astra introduced two important product families onto the Swedish market in 1948: penicillin and anaesthetics, initially in the form of Xylocaine.
Listen to how pharmaceutical brands and clinicians are adapting to this new modality and are pivoting their promotional efforts to ensure that they can leverage the Telehealth channel effectively. Panelists: Tim Glennon , Vice President of Marketing, Evofem Biosciences. Tres Garcia , Director Marketing, Agile Chapter Lead, Merck.
RJ Lewis (EHS): Hello, this is RJ Lewis and we’re back for Episode 2 with John Mack and Don Langsdorf, and we’re talking about the rebirth of Pharma Marketing and Pharma Guy. So, you continue with Pharma Marketing news. So they all do things that they do very well and they cover the market very well.
Bigdata analysis can be enormously powerful in providing insights for business strategy throughout the pharma value chain, including in the acceleration of drug discovery and development, optimization of manufacturing processes, management of supply chains and the creation of innovative sales and marketing strategies.
Choosing high-quality equipment for conducting calibrations on instruments can augment the instrument efficiency, accuracy, safety, and overall performance and enhance the brand value of the companies performing the analysis, testing, or measurement. Please check your email to download the Buyer's Guide.
We organize all of the trending information in your field so you don't have to. Join 21,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content